U.S. health officials have told more than a half-dozen of the nation’s top medical organizations that they will no longer ...

U.S. Food and Drug Administration officials should encourage the thoughtful and careful evaluation of drugs.

Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...

The FDA has released a report to educate the public regarding the dangers of 7-OH and its distinction from the kratom plant leaf.

FDA Commissioner Marty Makary said the FDA’s review process will not slow down despite layoffs at the Department of Health ...

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach ...

The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center for Drug ...

The Food and Drug Administration commissioner reveals what health officials are prioritizing in a forthcoming report on childhood chronic disease.

“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...

DSHEA struck a balance between providing easy, affordable access to dietary supplements and maintaining safety and efficacy ...